Pharmaceuticals The most-up-to-date pharmaceutical news stories, including medical, cosmetic, and supplemental treatments. This section contains releases covering all aspects of the pharmaceutical sector, from research, development, and testing, through to product launches and marketing. Topics include clinical trials and studies, as well as updates on the FDA approval process for new treatment options. Learn about upcoming events, conferences, and educational initiatives. Also included is financial and corporate information from the sector, such as board decisions, appointments and changes, industry awards, and quarterly reports.

Latest

06:15 ET Technical Perspectives on Horizon Pharma, Akari Therapeutics, MYOS RENS Technology, and Zynerba Pharma

In keeping with the commitment to dynamically provide members with timely information, WallStEquities.com has issued free tailored Stock Review on...


06:02 ET Egalet Receives FDA Tentative Approval for Expanded Label for ARYMO® ER (morphine sulfate) C-II, an Extended-Release Morphine Product Formulated with Abuse-Deterrent Properties for Treatment of Chronic Pain

Egalet Corporation (Nasdaq: EGLT) (Egalet), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and...


06:00 ET UpScript Offers Teva's Generic of Viagra®

This week, UpScript began offering the first generic version of Viagra, manufactured by Teva Pharmaceuticals. The popular erectile dysfunction...


04:00 ET PharmaVentures Capital Limited Advises Biosceptre International Limited, a Clinical Stage Oncology Company, on its Series A Private Placement by Tuspark S&T

PharmaVentures Capital Limited is pleased to announce that it acted as adviser to Biosceptre International Limited ("Biosceptre") for the...


Dec 14, 2017, 17:45 ET Global Octadecanedioic Acid Market 2017-2021 with Caming Pharmaceutical, Croda International, Elevance Renewable Sciences, HIMOUNT EUROPE, LGC & TCI AMERICA Dominating

The "Global Octadecanedioic Acid Market 2017-2021" report has been added to Research and Markets' offering. The global octadecanedioic acid...


Dec 14, 2017, 16:19 ET Millennium Health Appoints Robert H. Fish as Interim Chief Executive Officer

Millennium Health, a leading health solutions company, is pleased to announce the appointment of Robert "Bob" H. Fish as interim Chief Executive...


Dec 14, 2017, 16:06 ET AMCP Forum Discusses Strategies, Standards for Ushering in Era of Precision Medicine

"Precision medicine is no longer emerging, it's happening now," according to Susan A. Cantrell, RPh, CAE, CEO of the Academy of Managed Care...


Dec 14, 2017, 16:00 ET Amgen Teams Up With Cambridge Biotech Community To Select Two Startups To Receive Golden Tickets At LabCentral

Amgen (NASDAQ:AMGN) and LabCentral today announced that Kernal Biologics Inc. and QurAlis have won the Amgen Golden Ticket at LabCentral. The two...


Dec 14, 2017, 16:00 ET BioMatrix SpRx Selected As Authorized Provider Of Hemlibra

BioMatrix SpRx today announced they have been selected as an authorized specialty pharmacy provider of Genentech's new drug, Hemlibra...


Dec 14, 2017, 15:57 ET Pneuma Respiratory selected to present at Biotech Showcase during 2018 J.P. Morgan Healthcare Conference

Pneuma Respiratory, which has developed the first fully digital, breath-activated soft mist inhaler, will make two presentations at the BioTech...


Dec 14, 2017, 15:45 ET Global Pharmaceutical Excipients Procurement Market Report 2017 Featuring BASF, Ashland, Dow Chemical, ADM & Evonik Industries

The "Global Pharmaceutical Excipients - Procurement Market Intelligence Report" report has been added to Research and Markets' offering. Global...


Dec 14, 2017, 12:30 ET Rimidi and Lilly Collaborate to Personalize Solutions for People Using Insulin

Rimidi, a digital health company that provides software and clinical analytics for chronic disease management, and Eli Lilly and Company (NYSE:...


Dec 14, 2017, 11:33 ET Mérieux Développement entre au capital des Laboratoires Ineldea, afin d'accélérer son expansion commerciale en France et à l'international

Les Laboratoires Ineldea, société française spécialisée dans la formulation, le développement et la commercialisation de produits de santé...


Dec 14, 2017, 11:13 ET Mérieux Développement Becomes Reference Shareholder of Ineldea, to Accelerate its Commercial Expansion in France and Internationally

Laboratoires Ineldea, a French company specialized in the formulation, development and marketing of natural health products, announced the...


Dec 14, 2017, 10:17 ET Medicure Acquires Exclusive License to Sell and Market Branded Cardiovascular Drug in the U.S.

WINNIPEG, Dec. 14, 2017 /PRNewswire/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a pharmaceutical company, today announced...


Dec 14, 2017, 09:40 ET Kitov Announces Consensi™ as Brand Name for KIT-302

Kitov Pharmaceuticals (NASDAQ: KTOV) (TASE: KTOV), an innovative biopharmaceutical company, announced today that the U.S. Food & Drug...


Dec 14, 2017, 09:00 ET Medical Cannabis Sales Increase as Legalization Spreads in the USA

Medical benefits of cannabis, specifically patients suffering from chronic pain, diabetes, and cancer have driven the medical cannabis market. The...


Dec 14, 2017, 08:56 ET BioSight Announces Phase I/II Results of its Cytarabine Pro-Drug BST-236 for Treatment of Acute Leukemia

BioSight Ltd, a pharmaceutical development company, focused on the development of targeted oncology drugs, reports positive final results in a...


Dec 14, 2017, 08:47 ET BioVectra and Keryx Biopharmaceuticals Enter Agreement for Ferric Citrate Production Expansion

BioVectra Inc., an innovative global contract development and manufacturing organization (CDMO), today announced a long-term supply agreement with...


Dec 14, 2017, 08:18 ET Medimetriks Pharmaceuticals, Inc. Receives FDA Approval for Xepi™ (ozenoxacin) Cream, 1%, a Novel Topical Antibiotic for Impetigo

Medimetriks Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) approved Xepi™ (ozenoxacin) Cream, 1%, a new...


Dec 14, 2017, 08:00 ET Trovagene Submits Protocol to FDA for Phase 2 Clinical Trial of PCM-075 in Combination with Zytiga® for Metastatic Castration-Resistant Prostate Cancer

Trovagene, Inc. (NASDAQ: TROV), a precision medicine biotechnology company, engaged in the development of targeted cancer therapies, today...


Dec 14, 2017, 08:00 ET OncoSec Announces Dosing of First Patient in Registration-Directed Phase 2b Clinical Trial, PISCES/KEYNOTE-695, of ImmunoPulse® IL-12 in Combination with Pembrolizumab

OncoSec Medical Incorporated ("OncoSec" or the "Company") (NASDAQ:ONCS), a company developing intratumoral cancer immunotherapies, today announced...


Dec 14, 2017, 07:54 ET AbbVie Anuncia Estudo de Fase 3 com Venetoclax, em Combinação com Rituximabe, Atinge Objetivo Primário para Tratamento da Leucemia Linfoide Crônica

- Resultados do estudo MURANO, Fase 3, foram apresentados pela primeira vez, durante o 59o Encontro Anual da Sociedade Americana de...


Dec 14, 2017, 07:30 ET Express Scripts Holding Company Updates 2017 Full-Year Guidance and Announces 2018 Financial Guidance

Express Scripts Holding Company (Nasdaq: ESRX) increased its previously issued consolidated 2017 full-year adjusted EPS guidance range of $6.97 to...


Dec 14, 2017, 07:30 ET Mylan Announces the U.S. Patent and Trademark Appeal Board Institutes Inter Partes Review Proceedings on All Claims Against Sanofi's Lantus® Patents

Mylan N.V. (NASDAQ, TASE: MYL) today announced that the U.S. Patent and Trademark Appeal Board (PTAB) has instituted inter partes review...